ORAL COMBINATION PREPARATION COMPRISING GEMIGLIPTIN AND DAPAGLIFLOZIN AND METHOD FOR PREPARING THEREOF

The present invention relates to an oral combination preparation for efficiently treating type 2 diabetes, and more particularly, relates to an oral combination preparation for treating type 2 diabetes containing, as active components, gemigliptin or a pharmaceutically acceptable salt thereof, dapag...

Full description

Saved in:
Bibliographic Details
Main Authors LEE SUN, PARK MYEONG HYEON, JANG JOO MYUNG, AHN JAE SOON, KIM DONG MIN
Format Patent
LanguageEnglish
Korean
Published 20.04.2022
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to an oral combination preparation for efficiently treating type 2 diabetes, and more particularly, relates to an oral combination preparation for treating type 2 diabetes containing, as active components, gemigliptin or a pharmaceutically acceptable salt thereof, dapagliflozin or a pharmaceutically acceptable salt thereof, and lactose and/or microcrystalline cellulose disintegrants, and lubricant as bulking agents, and a method for manufacturing the same. 본 발명은 제2형 당뇨병을 효율적으로 치료하기 위한 경구용 복합제제에 관한 것으로, 보다 상세하게는 유효성분으로 제미글립틴 또는 이의 약제학적으로 허용가능한 염 및 다파글리플로진 또는 이의 약제학적으로 허용가능한 염, 증량제로 유당 및/또는 미결정 셀룰로오스; 붕해제; 및 활택제를 포함하는 제2형 당뇨병 치료용 경구용 복합제제, 및 이의 제조 방법에 관한 것이다.
Bibliography:Application Number: KR20210134776